IMU 2.35% 8.3¢ imugene limited

IMU has been remiss in HerVaxx reporting. The trial started in...

  1. 1,070 Posts.
    lightbulb Created with Sketch. 1085
    IMU has been remiss in HerVaxx reporting. The trial started in Aug-2017 and was to have recruited 68 patients. After over three years, it only recruited 27. We got no indication that the trial was so far behind schedule.

    Of those 27, only 14 were given Her-Vaxx. So this $500m+ company is valued on the apparent benefit on average of the 14 patients given Her-Vaxx vs those that weren't. 14 is not a sample size on which any regulatory authority can give permission to a company to market a drug.

    By the company's own admission, its most advanced trial (Her-Vaxx) will take until end 2021 just to get to the 34 patients that the IDMC has recommended. This still won't be enough to pass regulatory hurdles.

    There is no reporting on the efficacy of any of its other drugs in sight. There is no drug approval in sight. There is no revenue in sight. Given its R&D program, the company cannot get to revenue even with its current cash reserves.

    So all anyone with IMU shares has is a lottery ticket to a "Big Pharma" licensing deal or acquisition of one or more of its pipeline drugs.

    The cheer squad on this site continue to roll out numbers of other takeovers or licensing deals and then convert this into a multi-billion dollar valuation for IMU. Not one of those deals has been done with a company that has dosed just 14 patients with its products, yet that is the "beautiful data" the company has been touting and on which the cheer squad rely.

    So, its not clear why anyone believes the SP will rise steadily. It had its run based on the reporting of 14 patients - which was positive but not statistically significant. (As an aside, if the company had failed to report on its lack of progress with HER-Vaxx, gotten to the end of its original 3-year trial plan with less than 50% recruited and not received positive feedback from the IDMC, I think you'd currently be looking at a sub-1c SP).

    The SP will jump significantly if a big pharma deal comes along. Will it come? When will it come? are question no one on this site can answer. Do you want to be holding a ticket in the lottery in case it does come - its up to you - but at least understand that that is what you have.

    And before the cheer squad abuses me again, save it. Its not me you need to convince. Its all those nameless, faceless, unidentifiable sellers that have taken the SP from 14c to 10.5c as each of them apply their personal risk appetite to the information presented above - which most of them know, but don't post about on HC.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
-0.002(2.35%)
Mkt cap ! $607.5M
Open High Low Value Volume
8.4¢ 8.5¢ 8.2¢ $953.1K 11.48M

Buyers (Bids)

No. Vol. Price($)
1 40556 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 216619 4
View Market Depth
Last trade - 16.10pm 25/04/2024 (20 minute delay) ?
Last
8.4¢
  Change
-0.002 ( 1.42 %)
Open High Low Volume
8.4¢ 8.5¢ 8.2¢ 6636401
Last updated 15.59pm 25/04/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.